QID 242353

Date Published: 2023-11-15

QID 242353: Red Hat Update for pcs security (RHSA-2023:6316)

The pcs packages provide a command-line configuration system for the pacemaker and corosync utilities...Security Fix(es):

    decode-uri-component: improper input validation resulting in dos (cve-2022-38900).
Affected Products:
    Red Hat enterprise linux high availability for x86_64 9 x86_64.
    Red hat enterprise linux resilient storage for x86_64 9 x86_64.
    Red hat enterprise linux resilient storage for ibm z systems 9 s390x.
    Red hat enterprise linux high availability for ibm z systems 9 s390x.
    Red hat enterprise linux resilient storage for power, little endian 9 ppc64le.
    Red hat enterprise linux high availability for power, little endian 9 ppc64le.
    Red hat enterprise linux high availability for arm 64 9 aarch64.
.

Note: The preceding description block is extracted directly from the security advisory. Using automation, we have attempted to clean and format it as much as possible without introducing additional issues.

Successful exploitation of this vulnerability could lead to a security breach or could affect integrity, availability, and confidentiality.

  • CVSS V3 rated as High - 7.5 severity.
  • CVSS V2 rated as Medium - 5.4 severity.
    • Solution
    Refer to Red Hat security advisory RHSA-2023:6316 for updates and patch information.
    Vendor References

    CVEs related to QID 242353

    CVE-2022-38900 |
    Software Advisories
    Advisory ID Software Component Link
    RHSA-2023:6316 Red Hat Enterprise Linux URL Logo access.redhat.com/errata/RHSA-2023:6316
    By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].